AI Article Synopsis
- Posterior capsule opacification (PCO) is a common issue after cataract surgery, caused by lens epithelial cells attaching to the intraocular lens (IOL).
- A new technique was developed to create a highly swollen multilayer of hyaluronic acid (HA) and chitosan (CHI) on the IOL, which has hydrogel-like properties and significantly inhibits LEC adhesion and growth.
- In tests, this modified IOL maintained its optical quality and showed excellent biocompatibility in vivo, effectively reducing PCO development.
Article Abstract
Posterior capsule opacification (PCO) is a significant complication of intraocular lens (IOL) implantation in cataract surgery, in which the adhesion and proliferation of lens epithelial cells (LECs) on the IOL surface play important roles. In the present study, a highly swollen hyaluronic acid (HA)/chitosan (CHI) polyelectrolyte multilayer was fabricated on the IOL surface via the layer by layer technique. Quartz crystal microbalance with dissipation (QCM-D) results not only show the successful construction of the multilayer, but also indicate its hydrogel-like swollen property. The water content of the (HA/CHI) multilayer is around 400%, as obtained by thermogravimetry (TG) analysis. Compared with a pristine IOL, the polysaccharide multilayer modification does not influence its optical property, whereas the adhesion and proliferation of LECs are greatly inhibited. In vivo ocular implantation results show that such a polysaccharide multilayer modification presents good in vivo biocompatibility, and has positive effects on reducing PCO development.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1039/c5tb00111k | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!